APA (7th ed.) Citation

Pogue-Geile, K. L., Kim, C., Jeong, J., Tanaka, N., Bandos, H., Gavin, P. G., . . . Rastogi, P. (2013). Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31. JNCI: Journal of the National Cancer Institute, 105(23), 1782. https://doi.org/10.1093/jnci/djt321

Chicago Style (17th ed.) Citation

Pogue-Geile, Katherine L., et al. "Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31." JNCI: Journal of the National Cancer Institute 105, no. 23 (2013): 1782. https://doi.org/10.1093/jnci/djt321.

MLA (9th ed.) Citation

Pogue-Geile, Katherine L., et al. "Predicting Degree of Benefit From Adjuvant Trastuzumab in NSABP Trial B-31." JNCI: Journal of the National Cancer Institute, vol. 105, no. 23, 2013, p. 1782, https://doi.org/10.1093/jnci/djt321.